Corat Therapeutics Gmbh
1 clinical trials · Sponsor
◉ Watch Corat Therapeutics Gmbh
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 (NCT04674566) | Corat Therapeutics Gmbh | 2021-04-21 |
Track Corat Therapeutics Gmbh automatically
Every clearance here is in the API, with alerts when new ones post.